Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
05/2014
05/07/2014EP2727915A1 Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
05/07/2014EP2727909A1 Inhibitors of focal adhesion kinase
05/07/2014CN103781789A 用于治疗呼吸道合胞病毒感染的化合物 Compounds for the treatment of respiratory syncytial virus infection
05/07/2014CN103781785A 作为α2肾上腺素能受体的调节剂的N-(咪唑烷-2-亚基)-杂环戊并[b]吡啶衍生物 As α2 adrenergic receptor modulators N- (imidazol-2-ylidene) - heterocyclopentadienyl and [b] pyridine derivatives
05/07/2014CN103781780A 作为jak抑制剂的杂环基嘧啶类似物 As jak inhibitor heterocyclic pyrimidine analogs
05/07/2014CN103781776A 用作端锚聚合酶抑制剂的新的2-哌啶-1-基-乙酰胺化合物 Inhibitors used tankyrase new 2-piperidin-1-yl - acetamide compound
05/07/2014CN103772405A 双苄基四氢异喹啉类生物碱及其制备方法和应用 Dual-benzyl-tetrahydroisoquinoline alkaloid and its preparation method and application
05/07/2014CN103772404A 双苄基四氢异喹啉衍生物及其制备方法和应用 Dual-benzyl-tetrahydroisoquinoline derivative and its preparation method and application
05/07/2014CN103772403A 一种利用黄花石蒜提取加兰他敏的方法 A method of extracting yellow Lycoris galantamine use
05/07/2014CN103772402A 一种新的阿塞那平马来酸盐粗品精制方法 A new asenapine maleate crude refining methods
05/07/2014CN103772401A 11-氯-2,3,3a,12b-四氢-2-甲基-1H-二苯并[2,3:6,7]氧杂卓并[4,5-c]吡咯-1-酮的一种新精制方法 11- chloro -2,3,3a, 12b- tetrahydro-2-methyl -1H- dibenzo [2,3: 6,7] oxa-excellence and [4,5-c] pyrrole-1-one A new purification method
05/07/2014CN103772400A 反式-5-氯-2,3,3a,12b-四氢-1H-二苯并[2,3:6,7]氧杂卓并[4,5-c]吡咯的制备方法 Trans-5-chloro -2,3,3a, 12b- tetrahydro -1H- dibenzo [2,3: 6,7] oxa-excellence and [4,5-c] pyrrole prepared
05/07/2014CN103772371A 6-呋喃基喹唑啉-4-胺化合物及其制备方法和用途 6- furanyl quinazolin-4-amine compounds and their preparation and use
05/07/2014CN103772259A 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药 Aryl and heteroaryl acetic acids with positively charged prodrug with rapid skin penetration rate
05/07/2014CN103772258A 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药 Aryl and heteroaryl acetic acids with positively charged prodrug with rapid skin penetration rate
05/07/2014CN102627652B 一种脱氧河鲀毒素的提取方法 An extraction method deoxy puffer toxin
05/07/2014CN102146084B 3-氰基-6-氨基喹啉类衍生物、其制备方法及其在医药上的应用 3-cyano-6-amino-quinoline derivatives, their preparation and their applications in medicine
05/07/2014CN102026972B 螺[环烷基-1，3′-吲哚]-2′(1′H)-酮的取代衍生物及其作为p38促分裂原活化蛋白激酶抑制剂的应用 Spiro [cycloalkyl-1,3'-indol] -2 '(1'H) - one and its substituted derivatives as p38 mitogen-activated protein kinase inhibitors Applications
05/07/2014CN102007129B 用作治疗人类脑疾病的前药的雪花胺衍生物 Used as the pre-treatment of human brain diseases drug galantamine derivatives
05/07/2014CN101648950B 噻托铵盐、其医药制剂及其用途 Tiotropium salts, their pharmaceutical formulations and their use
05/06/2014US8716493 Multicyclic compounds and the use thereof
05/06/2014US8716329 Use of parthenolide derivatives as antileukemic and cytotoxic agents
05/06/2014US8716323 Cyclic protein tyrosine kinase inhibitors
05/06/2014US8716307 Combination antineoplastic therapy
05/06/2014US8716278 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
05/06/2014CA2658379C Spirocyclic azaindole derivatives
05/06/2014CA2592288C Process for the preparation of galanthamine hydrobromide
05/06/2014CA2574040C Iap binding compounds
05/01/2014WO2014065501A1 Organic compound and organic electroluminescent element comprising same
05/01/2014WO2014065300A1 Compound having acridan ring structure, and organic electroluminescence element
05/01/2014WO2014065215A1 Transparent electrode, electronic device, and organic electroluminescent element
05/01/2014WO2014064654A1 Derivatives of camptothecin, a method of producing them and their use
05/01/2014WO2014064076A1 Process for the preparation of a polymorph of asenapine maleate
05/01/2014WO2014063778A1 2-aminopyridine compounds
05/01/2014WO2014047393A9 N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
05/01/2014US20140121367 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
05/01/2014US20140121259 Novel crystalline asenapine hydrochloride salt forms
05/01/2014US20140121233 Synthesis and Characterization of Second Generation Benzofuranone Ring Substituted Noscapine Analogs
05/01/2014US20140121231 Pyranopyridone inhibitors of tankyrase
04/2014
04/30/2014CN103764658A Compounds, their pharmaceutical compositions and their uses as IDH1 mutants inhibitors for treating cancers
04/30/2014CN103764641A Partially saturated tricyclic compounds and methods of making and using same
04/30/2014CN103764629A Positive allosteric modulators of nicotinic acetylcholine receptor
04/30/2014CN103755716A Spiroketal-substituted cyclic ketoenols
04/30/2014CN103755715A Benzofuran [2, 3-c] pyridine compound and synthetic method thereof
04/30/2014CN101774938B Type of capsaicine derivative, preparation method thereof and medical use for preparing new analgesic thereof
04/30/2014CN101668742B Bridged six-membered ring compounds
04/29/2014US8710229 Hepatitis C virus inhibitors
04/29/2014US8710065 Tricyclic inhibitors of kinases
04/29/2014US8709431 Enediyne compounds, conjugates thereof, and uses and methods therefor
04/29/2014CA2721007C Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
04/29/2014CA2624307C Substituted benzofused derivatives and their use as vanilloid receptor ligands
04/29/2014CA2591438C Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
04/24/2014WO2014061963A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
04/24/2014WO2014061961A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
04/24/2014WO2014061031A1 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
04/24/2014WO2014060411A1 Rsv antiviral compounds
04/24/2014US20140113929 Macrocyclic inhibitors of hepatitis c virus
04/24/2014US20140113890 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
04/24/2014US20140113005 Compounds useful as inhibitors of atr kinase
04/24/2014US20140112885 Antiviral compounds
04/23/2014EP2721034A1 Tricyclic antibiotics
04/23/2014EP2721033A1 Compounds, their pharmaceutical compositions and their uses as idh1 mutants inhibitors for treating cancers
04/23/2014EP2721027A2 Z-selective ring-closing metathesis reactions
04/23/2014EP2721025A1 New selective ccr2 antagonists
04/23/2014EP2721008A1 Hydroxy substituted isoquinolinone derivatives
04/23/2014CN103748086A Pyridine-and pyrazine derivatives
04/23/2014CN103739596A Quinazoline derivative used for cardio cerebrovascular diseases
04/23/2014CN101983201B Optically active dibenzazepine derivatives
04/22/2014US8703953 Aryl ether-base kinase inhibitors
04/22/2014US8703952 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-γ-carboline and analogues and intermediates
04/22/2014US8703951 Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agents
04/22/2014US8703949 Tandem process for preparing N-alkyl morphinans
04/22/2014US8703796 3H-imidazo [4, 5-B] pyridine-6-carboxamides as anti-inflammatory agents
04/22/2014US8703794 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
04/22/2014US8703793 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
04/22/2014US8703792 C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation
04/22/2014US8703758 Bicyclic compound
04/17/2014WO2014058035A1 Novel spirooxindole derivative and process for producing the same
04/17/2014WO2014057685A1 Organic electroluminescent element
04/17/2014WO2014057684A1 Ladder compound, and organic electroluminescent element using same
04/17/2014WO2014057659A1 Compound, and organic electroluminescent element produced using same
04/17/2014US20140107143 Quaternary opioid carboxamides
04/17/2014US20140107142 Methods of use of cyclopamine analogs
04/17/2014US20140107117 Thienyl- and Furanyl-Isoquinolinones and Methods for Using Them
04/16/2014EP2719700A1 Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases
04/16/2014EP2719698A1 Methods for preparing aurora kinase inhibitors
04/16/2014EP2719679A1 Method for manufacturing optically active carboxylic acid ester
04/16/2014EP2718296A1 Synthesis and characterization of second generation benzofuranone ring substituted noscapine analogs
04/16/2014EP2718266A1 Pyridin- 2 -amides useful as cb2 agonists
04/16/2014EP2717874A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
04/16/2014CN103724655A Method for preparing epothilone molecularly imprinted polymer film by adopting mixed template
04/16/2014CN103724357A Synthetic method of 3, 4-dihydropyran [3, 2-b] indole-2-ketones compound
04/16/2014CN102574836B Aminopyrazole derivative
04/16/2014CN102531815B Method for asymmetrically catalyzing epoxidation reaction of alpha, beta-unsaturated carbonyl compounds
04/16/2014CN102477039B Method for preparing Fissistigma oldhamii lactam alkali compound and application thereof to preparing anti-tumour medicine
04/16/2014CN102443009B Fused ring kinase inhibitor
04/16/2014CN102127089B Method for extracting camptothecin
04/15/2014US8697719 Anhydrate of tiotropium bromide
04/15/2014US8697708 Azabenzothiazole compounds, compositions and methods of use
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 298